Li Zhong

Li Zhong


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
NWNa Wu
Na Wu
XCXinghua Chen
Xinghua Chen
TCTongjian Cai
Tongjian Cai
LWLong Wu
Long Wu
YXYing Xiang
Ying Xiang
LZLi Zhong
Li Zhong

17 April 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NWNa Wu
Na Wu
STShifei Tong
Shifei Tong
YXYing Xiang
Ying Xiang
LWLong Wu
Long Wu
BXBin Xu
Bin Xu
LZLi Zhong
Li Zhong
There is growing evidence that indicates the presence of a prothrombotic state in atrial fibrillation (AF). However, the role of hemostatic markers in AF remains inconclusive. We conducted a meta-analysis of observational studies to evaluate the association between hemostatic markers and AF. A meta-regression was performed to explore potential sources of heterogeneity. A total of 59 studies met our inclusion criteria for the meta-analysis. For platelet activation, increased circulating platelet factor-4, β-thromboglobulin (BTG) and P-selectin were significantly higher in AF cases compared with controls (standardized mean difference [SMD][95% confidence interval (CI)]: 1.72[0.96–2.49], 1.61[1.03–2.19] and 0.50[0.23–0.77], respectively). For coagulation activation, increased levels of plasma D-dimer, fibrinogen, thrombin-antithrombin, prothrombin fragment 1+2, and antithrombin-III were significantly associated with AF (SMD[95% CI]: 1.82[1.38–2.26], 0.72[0.55–0.89], 0.42[0.13–0.72], 1.00 [0.00–1.99] and 1.38[0.16–2.60], respectively). For fibrinolytic function, tissue-type plasminogen activator and plasminogen activator inhibitor-1 were significantly increased in AF cases compared with controls (SMD[95% CI]: 0.86[0.04–1.67] and 0.87[0.28–1.47], respectively) but the associations became nonsignificant after performing subgroup analysis by anticoagulants treatment status. For endothelial function, increased von Willebrand factor was significantly associated with AF (SMD, 0.79; 95% CI, 0.60–0.99); however, no association was observed for soluble thrombomodulin (SMD, 0.60; 95% CI, -0.13–1.33). Increased circulating hemostatic factors (PF-4, BTG, P-selectin, D-dimer, fibrinogen, TAT, F1+2, AT- III, and vWf) are significantly associated with AF. Future research is necessary to elucidate the precise mechanism of the prothrombotic state and how hemostatic markers promote thromboembolism in AF.

20 May 2016 in Scientific Reports
Verified
Journal Article
Open access
NWNa Wu
Na Wu
BXBin Xu
Bin Xu
YLYuan Liu
Yuan Liu
XCXinghua Chen
Xinghua Chen
HTHe Tang
He Tang
LZLi Zhong
Li Zhong
We performed a matched case-control study using a propensity score matching, to assess the association of Th17-related cytokines, including interleukin (IL) 17A (IL-17A), IL-17F, IL-21, IL-22 and IL-6, along with interferon-γ (IFN-γ), IL-10, IL-9 and IL-4, with the risk of AF. A total of 336 patients with AF were matched 1:1 with patients without AF. Plasma levels of cytokines were measured using Luminex xMAP assays. The plasma levels of all examined cytokines were significantly higher in AF patients than controls (P < 0.05) and these cytokines were highly correlated with each other (P < 0.01). A multivariate conditional logistic regression analysis showed that elevated plasma levels of IL-17A, IL-17F, IL-21, IL-22, IFN-γ, IL-10, IL-9 and IL-6 were significantly associated with AF risk independently of potential confounders. There were no significant differences in plasma levels of examined cytokines between paroxysmal and chronic AF patients. IL-17A, IL-21, IL-10 and IL-6 levels were positively correlated with left atrial diameter; IL-17F level was negatively correlated with left ventricle ejection fraction among AF patients (P < 0.05). Elevated plasma levels of Th17-related cytokines were independently associated with increased an risk of AF; hence, Th17-related cytokines may be involved in the pathogenesis of AF.

1 June 2016 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
YLYuan Liu
Yuan Liu
BXBin Xu
Bin Xu
NWNa Wu
Na Wu
YXYing Xiang
Ying Xiang
LWLong Wu
Long Wu
LZLi Zhong
Li Zhong

7 March 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
YZYuhong Zeng
Yuhong Zeng
NWNa Wu
Na Wu
ZZZhi-Hui Zhang
Zhi-Hui Zhang
LZLi Zhong
Li Zhong
GLGuowei Li
Guowei Li
YLYafei Li
Yafei Li
Arrhythmias are a class of cardiac dysfunction characterized by heart rate disturbances and heart rhythm abnormalities, which are associated with substantial morbidity and mortality. Due to the limited understanding of pathological mechanism, current antiarrhythmic drugs and invasive therapies on arrhythmias lack sufficient efficacy and are always accompanied by potential adverse effects. Non-coding RNAs (including microRNAs, long non-coding RNAs, circular RNAs, and other small non-coding RNAs) have been demonstrated to be involved in the occurrence and development of various diseases including arrhythmias, which opens a new prospect for exploring the mechanism of arrhythmias and developing new therapeutic targets. Therefore, in this review, we aimed to provide an overview of the expression of ncRNAs in various arrhythmias, their roles in the arrhythmia’s development and pathophysiology, and the potential mechanism of ncRNAs in arrhythmias. As atrial fibrillation (AF) is the most common arrhythmia in clinical practice and current studies mainly focus on it, this review primarily discussed about AF. It was expected that this review may provide a basis for a better understanding of the mechanistic role of ncRNAs in arrhythmias and facilitate the development of mechanic-based therapeutic targets.

8 May 2020 in Skeletal Radiology
Verified
Journal Article
Closed access
PDF file
DWDongdong Wang
Dongdong Wang
HYHuijia Yin
Huijia Yin
WLWenling Liu
Wenling Liu
LZLi Zhong
Li Zhong
JRJipeng Ren
Jipeng Ren
HDHan Dongming
Han Dongming